SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : transgenics
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: nigel bates who wrote (9)9/5/2000 7:09:20 PM
From: scaram(o)uche   of 41
 
make note, Gruntal and Company.....

These and other companies can now make monoclonal antibodies rapidly
and relatively inexpensively, said Darren Mac, an analyst at Gruntal & Co.

"The key question is what sort of yield the companies will get" and
whether it's competitive cost-wise, he said of the Dow-EPI partnership.
Mac also said there may be similar issues with plant allergens as there
were with partially human antibodies.

cbs.marketwatch.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News